Cargando…

The Impact of Multidrug-Resistant Organisms on Outcomes in Patients With Diabetic Foot Infections

BACKGROUND: Multidrug-resistant organisms (MDROs) are important diabetic foot infection (DFI) pathogens. This study evaluated the impact of DFIs associated with MDRO pathogens (DFI-MDRO) on clinical outcomes. METHODS: Adults admitted to Detroit Medical Center from January 2012 to December 2015 with...

Descripción completa

Detalles Bibliográficos
Autores principales:	Henig, Oryan, Pogue, Jason M, Martin, Emily, Hayat, Umar, Ja’ara, Mahmoud, Kilgore, Paul E, Cha, Raymond, Dhar, Sorab, Kaye, Keith S
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Major Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7255643/ https://www.ncbi.nlm.nih.gov/pubmed/32500092 http://dx.doi.org/10.1093/ofid/ofaa161

Ejemplares similares

Epidemiology of Diabetic Foot Infection in the Metro-Detroit Area With a Focus on Independent Predictors for Pathogens Resistant to Recommended Empiric Antimicrobial Therapy
por: Henig, Oryan, et al.
Publicado: (2018)

Minocycline for the Treatment of Multidrug and Extensively Drug-Resistant A. baumannii: A Review
por: Lashinsky, Jennifer N., et al.
Publicado: (2017)

Rethinking the “Pan-Culture”: Clinical Impact of Respiratory Culturing in Patients With Low Pretest Probability of Ventilator-Associated Pneumonia
por: Albin, Owen R, et al.
Publicado: (2022)

2075. The Hypothetical Impact of Accelerate Pheno on Time to Appropriate Therapy (TTAT) and Time to Optimal Therapy (TTOT) in an Institution with an Established Antimicrobial Stewardship Program and Rapid Genotypic Organism/Resistance Marker Identification
por: Cooper, Christopher, et al.
Publicado: (2018)

Deferring Amputation in Diabetic Foot Osteomyelitis: Doing More Harm Than Good?
por: Zhou, Shiwei, et al.
Publicado: (2021)

318. Deferring Amputation in Diabetic Foot Osteomyelitis: Doing more Harm than Good?
por: Zhou, Shiwei, et al.
Publicado: (2020)

The hypothetical impact of Accelerate Pheno™ system on time to effective therapy and time to definitive therapy in an institution with an established antimicrobial stewardship programme currently utilizing rapid genotypic organism/resistance marker identification
por: Henig, Oryan, et al.
Publicado: (2019)

Overview of meropenem-vaborbactam and newer antimicrobial agents for the treatment of carbapenem-resistant Enterobacteriaceae
por: Petty, Lindsay A, et al.
Publicado: (2018)

Bacterial Pneumonia in Older Adults
por: Henig, Oryan, et al.
Publicado: (2017)

1467. Clinical Significance of Microbiologic Treatment Failure Following Clinical Cure of Pneumonia
por: Albin, Owen, et al.
Publicado: (2018)

Clinical Outcomes With Extended Versus Intermittent Infusion of Anti-Pseudomonal Beta-Lactams in Patients With Gram-Negative Bacteremia
por: Tran, Nikki N, et al.
Publicado: (2023)

2222. Impact of Empiric Aminoglycoside Usage on Outcomes in Bacterial Pneumonia
por: Albin, Owen, et al.
Publicado: (2019)

Empirical Antibiotic Therapy in Diabetic Foot Ulcer Infection Increases Hospitalization
por: Schmidt, Brian M, et al.
Publicado: (2023)

A Prospective Observational Study of the Epidemiology, Management, and Outcomes of Skin and Soft Tissue Infections Due to Carbapenem-Resistant Enterobacteriaceae
por: Henig, Oryan, et al.
Publicado: (2017)

Unraveling a Nosocomial Outbreak of COVID-19: The Role of Whole-Genome Sequence Analysis
por: Meijer, Suzy E, et al.
Publicado: (2021)

1567. Predicting Mortality Among Immunocompromised Patients Who Present with Infection
por: Henig, Oryan, et al.
Publicado: (2018)

Intra-abdominal Infections: The Role of Anaerobes, Enterococci, Fungi, and Multidrug-Resistant Organisms
por: Marcus, Gil, et al.
Publicado: (2016)

Ultraviolet-C Light Evaluation as Adjunct Disinfection to Remove Multidrug-Resistant Organisms
por: Rock, Clare, et al.
Publicado: (2021)

Infectious Diseases Consultation Reduces 30-Day and 1-Year All-Cause Mortality for Multidrug-Resistant Organism Infections
por: Burnham, Jason P, et al.
Publicado: (2018)

223. Predicting Mortality Among Immunocompromised Patients Who Present With Bloodstream Infection
por: Henig, Oryan, et al.
Publicado: (2019)

Optimizing the Management of Uncomplicated Gram-Negative Bloodstream Infections: Consensus Guidance Using a Modified Delphi Process
por: Heil, Emily L, et al.
Publicado: (2021)

Predicting Risk of Multidrug-Resistant Enterobacterales Infections Among People With HIV
por: Henderson, Heather I, et al.
Publicado: (2022)

Comparison of fidaxomicin to oral vancomycin for the treatment of Clostridioides difficile infection in hospitalized patients
por: Rao, A. Krishna, et al.
Publicado: (2022)

Multidrug Resistance of Escherichia coli From Outpatient Uncomplicated Urinary Tract Infections in a Large United States Integrated Healthcare Organization
por: Ku, Jennifer H, et al.
Publicado: (2023)

Assessment of Testing and Treatment of Asymptomatic Bacteriuria Initiated in the Emergency Department
por: Petty, Lindsay A, et al.
Publicado: (2020)

Ceftolozane-Tazobactam for the Treatment of Multidrug-Resistant Pseudomonas aeruginosa Infections: A Multicenter Study
por: Gallagher, Jason C, et al.
Publicado: (2018)

Association Between Foot Surgery Type and Subsequent Healing in Veterans With Moderate-to-Severe Diabetic Foot Infections
por: Kim, Justin J, et al.
Publicado: (2021)

A Multicenter Evaluation of Ceftolozane/Tazobactam Treatment Outcomes in Immunocompromised Patients With Multidrug-Resistant Pseudomonas aeruginosa Infections
por: Hart, Delaney E, et al.
Publicado: (2021)

Crossroads of Antimicrobial and Diagnostic Stewardship: Assessing Risks to Develop Clinical Decision Support to Combat Multidrug-Resistant Pseudomonas
por: Zou, Iris, et al.
Publicado: (2023)

Cefiderocol: A Novel Agent for the Management of Multidrug-Resistant Gram-Negative Organisms
por: Wu, Janet Y., et al.
Publicado: (2020)

Incidence and Severity of Drug Interactions Before and After Switching Antiretroviral Therapy to Bictegravir/Emtricitabine/Tenofovir Alafenamide in Treatment-Experienced Patients
por: Schafer, Jason J, et al.
Publicado: (2020)

Low-Dose Linezolid for Treatment of Patients With Multidrug-Resistant Tuberculosis
por: Mase, Anjeli, et al.
Publicado: (2022)

Investigating Epidemiologic and Molecular Links Between Patients With Community- and Hospital-Acquired Influenza A: 2017–2018 and 2019–2020, Michigan
por: Wan, Tiffany, et al.
Publicado: (2023)

Standardized Treatment and Assessment Pathway Improves Mortality in Adults With Methicillin-resistant Staphylococcus aureus Bacteremia: STAPH Study
por: Alosaimy, Sara, et al.
Publicado: (2021)

Model-Based Efficacy and Toxicity Comparisons of Moxifloxacin for Multidrug-Resistant Tuberculosis
por: Yun, Hwi-Yeol, et al.
Publicado: (2021)

Minimizing Time to Optimal Antimicrobial Therapy for Enterobacteriaceae Bloodstream Infections: A Retrospective, Hypothetical Application of Predictive Scoring Tools vs Rapid Diagnostics Tests
por: Cwengros, Laura N, et al.
Publicado: (2020)

Enterococci in Diabetic Foot Infections: Prevalence, Clinical Characteristics, and Outcomes
por: Perzon, Ofer, et al.
Publicado: (2023)

2415. Comparison of Minocycline MIC’s Obtained by Etest to Those Obtained by Broth Microdilution in a Bank of Isolates of Acinetobacter baumannii Collected in Southeastern Michigan
por: Parsons, Leo, et al.
Publicado: (2018)

Real-World Experience With Ceftazidime-Avibactam for Multidrug-Resistant Gram-Negative Bacterial Infections
por: Jorgensen, Sarah C J, et al.
Publicado: (2019)

Old In Vitro Antimicrobial Breakpoints Are Misleading Stewardship Efforts, Delaying Adoption of Innovative Therapies, and Harming Patients
por: Ambrose, Paul G, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_8lst9vjcvpoqejrjb86lii4psm